Infographic: The pipeline for long-acting HIV formulations
In this infographic we take a look at the long-acting formulations for HIV prevention and treatment currently in the clinical pipeline – from Phase I to approval.
Browsing: Clinical Trial
WHO prequalifies Ebola vaccine: November’s industry headlines
Take a look at this month’s industry headlines including results for Takeda’s dengue vaccine, approvals for Merck’s Ebola vaccine and the advent of a siderophore antibiotic – the first of this kind.
Pneumonia, ICU patients and potential treatments – an interview with Keith Kaye
In this interview we speak to Keith Kaye, from the University of Michigan (MI, USA) about the RESTORE-IMI 2 study, its results and why ICU patients represent an unmet need.
Clinical trial reveals promising tuberculosis vaccine candidate
A clinical trial conducted in sub-Saharan African countries over 3 years, has revealed a candidate vaccine for tackling tuberculosis. The candidate vaccine, M72/AS01E, was reported to be 54% effective at preventing active pulmonary tuberculosis disease.
US FDA approves first rapid diagnostic test for Ebola: October’s industry headlines
Take a look at this month’s industry headlines including US FDA approvals for XOFLUZATM and…
US FDA approvals for antibiotic Xenleta™ and tuberculosis drug Pretomanid: August’s industry headlines
Take a look at this month’s industry headlines including US FDA approvals for two drugs – Xenleta™ and Pretomanid – in addition to an EMA decision for Zerbaxa®, partnerships for vaccine development and results on Ebola therapeutics.
First new oral and IV antibiotic with novel mechanism of action approved in nearly two decades
Xenleta™ (lefamulin), developed by Nabriva Therapeutics, has been approved by the US FDA for adults with community-acquired bacterial pneumonia, marking the first new antibiotic with a novel mechanism of action to be approved in nearly two decades.
US FDA approves Pretomanid tablets for drug-resistant tuberculosis
The US FDA has approved Pretomanid tablets in combination with bedaquiline and linezolid for the treatment of specific types of drug-resistant pulmonary tuberculosis.
Two Ebola treatments prove effective in DRC outbreak
A study of four Ebola therapeutics demonstrated that two drugs showed significantly improved survival rates, leading to the trial being halted early.
First chlamydia vaccine to reach Phase I trial appears safe and immunogenic
The first chlamydia vaccine to reach Phase I clinical trials has been observed to be safe and immunogenic in 35 women.
